Urinary Albumin-Creatinine Ratio in Chronic Kidney Disease

Elevated. Studies summarised in the OSMF atlas report higher Urinary Albumin-Creatinine Ratio in Chronic Kidney Disease than in the reference group of the cited comparison (CKD vs physiological/normal levels). Source: Ruilope et al. 2023.

The atlas record does not list a standardised clinical test code (LOINC) for Urinary Albumin-Creatinine Ratio, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.

No. No single biomarker is diagnostic of Chronic Kidney Disease. Urinary Albumin-Creatinine Ratio findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

No. The same marker is also reported in Hypertension in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.